News & Insights
Analysis and perspectives on pharmaceutical pricing, market access, IRP, MFN policy, and AI-powered pricing tools.
Stay up to date with the latest developments in pharmaceutical pricing policy, including GENEROUS, MFN, and International Reference Pricing.
-
Decoding GLOBE & GUARD: Medicare’s New MFN Models
Policy Analysis GLOBE & GUARD: MFN Pricing Comes to Medicare January 2026 • 10 min read In December 2025, CMS released proposed rules for two…
-
GENEROUS: Medicaid’s MFN test—what it is, why it matters now
Policy Analysis GENEROUS: MFN Comes to Medicaid How CMS is turning international reference pricing into guaranteed net prices for state drug programs January 2026 •…
Stay Updated
Get in touch to learn more about our AI-powered pharmaceutical pricing tools and stay informed on the latest policy developments.